Medizone Meets ALL Qualifications for Serious Upside
With the Third Round of AsepticSure trials under way Medizone International, Inc. has the classic track record for a stock that is about to become a serious company. I have been following this for a while.
Your first step in due diligence should be to look at the company’s website: http://Medizoneint.com
Last week I discussed the qualifications of the Chief of Research — Dr. Michael Shannon, which are nothing short of amazing.
This week I am asking you to go Medizone’s website and listen to his presentation.
You will quickly see this company is addressing a serious problem with a REAL solution.
The product is AsepticSure(TM).
First and second rounds of laboratory testing are complete.
The Company is involved in its third round.
A development prototype is being finalized in order to conduct a full room scale hospital mock up.
The AsepticSure(TM) system is on track for real sales, SOON.
This is what you wait and wait and wait for in a biotech company. SALES.
That’s where we are.
The problems is REAL.
The head of research has serious credentials (see last weeks post).
This bio-tech company looks like it is ABOUT TO DELIVER.
If there was ever a time to buy a bio-tech … it is now and this is THE company.
Medizone International, Inc. (MZEI.OB)
Post Office Box 742
Stinson Beach, CA 94970
Telephone: 415-868-0300
Email: operations@medizoneint.com
MZEI.OB Medizone International, Inc. is traded on the Over the Counter Bulletin Board (OTCBB) under the symbol MZEI.OB.
Pentony Enterprises LLC is STOCKGURU.COM, SHAREHOLDERVISION.COM and STREETRESEARCH.COM. 9555 Lebanon Road; Suite 103; Frisco, Texas 75035. (469) 252-3030. Disclosure: Pentony Enterprises LLC was compensated seventy-two hundred dollars and 450,000 144 restricted common shares by the company for profile coverage for the period ending September 15, 2009. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
